The Active After Cancer Trial (AACT)
The Active After Cancer Trial (AACT)
Active, not recruiting · NCT00548236 · Registry updated 2026-02-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Active After Cancer Trial (AACT) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder, skin disorder | Active, not recruiting | Not applicable | 2026-02-23 | NCT00548236 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cancer and Leukemia Group B | 3 |
| Dana-Farber Cancer Institute | 324 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana-Farber Cancer Institute | Boston | United States | 68 |
| Hematology Oncology Associates of Central New York | East Syracuse | United States | 7 |
| Lakes Regional Healthcare Hematology Oncology | Hooksett | United States | 1 |
| New Hampshire Oncology Hematology | Concord | United States | 1 |
| Ohio State University | Columbus | United States | 169 |
| Rosewell Park Cancer Institute | Buffalo | United States | 3 |
| University of California at San Diego | La Jolla | United States | 4 |
| University of California San Francisco | San Francisco | United States | 144 |
| Vermont Cancer Center | Burlington | United States | 1 |